We also investigated the correlations between FNDC3B expression and tumor immune microenvironment (TIM) in LGG patients in order to elucidate the underlying mechanisms and improve molecular diagnosis for glioma patients. This evidence concerns the gene FNDC3B and central nervous system cancer.